Non-small cell lung cancer: clinical value of new biological predictors (Q41523353)

2 October 2017

1 reference

title

Non-small cell lung cancer: clinical value of new biological predictors (English)

1 reference

2 October 2017

Graziano SL

1

1 reference

2 October 2017

1 June 1997

1 reference

2 October 2017

1 reference

2 October 2017

17 Suppl 1

1 reference

2 October 2017

S37-58

1 reference

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group

2 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 CM in diameter

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic and therapeutic significance of the flow cytometric nuclear DNA content in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Ploidy as a prognostic determinant in surgically treated lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic significance of the expression ofras oncogene product in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Expression of Blood-Group Antigen A — A Favorable Prognostic Factor in Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Nonanatomic prognostic factors in carcinoma of the lung: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Survival in early-stage non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Incidence of local recurrence and second primary tumors in resected stage I lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Vascular invasion in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Flow cytometric analysis of the DNA content of non-small cell lung cancer. Ploidy as a significant prognostic indicator in squamous cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

A flow cytometric study of non-small cell lung cancer classified as T1N0

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Ki-67 immunostaining and survival in operable lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

DNA polymerase-alpha as a putative early relapse marker in non-small cell lung cancer. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic significance of Ki67 labelling in resected non small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, node-negative non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Relation of neovascularisation to metastasis of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

The histopathological evaluation of nucleolar organizer region proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

A, B, H antigens in transitional cell tumors of the urinary bladder.Correlation with the clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Expression of blood group antigen A by stage I non-small cell lung carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Immunostains for blood group antigens lack prognostic significance in T1 lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Blood group ABH-related antigens in normal and malignant bladder urothelium: possible structural basis for the deletion of type-2 chain ABH antigens in invasive carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Correlation of Expression of H/LeY/LeBAntigens with Survival in Patients with Carcinoma of the Lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Expression of Lewis-related antigen and prognosis in stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic Factors in Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

The neu oncogene encodes an epidermal growth factor receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Implications of the p53 tumor-suppressor gene in clinical oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

p53: from molecular mechanisms to prognosis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

p53: a frequent target for genetic abnormalities in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

The relationship of p53 immunostaining to survival in carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Immunohistochemical detection of P53 protein is not associated with a poor prognosis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Immunohistochemical detection of p53 in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inlet

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Microvessel count predicts metastatic disease and survival in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Breast cancer prognostic factors: evaluation guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2897%2900639-9

7 January 2021

10.1016/S0169-5002(97)00639-9

Identifiers

DOI

1 reference

2 October 2017

1 reference

PubMed ID

9213302